MC
AGN

Mathes Company’s Allergan plc AGN Stock Holding History

Mathes Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,231
Closed -$1.44M – 141
2016
Q3 		$1.44M Sell
6,231
-150
-2% -$36.7K 0.81% 42
2016
Q2 		$1.48M Sell
6,381
-470
-7% -$108K 0.86% 40
2016
Q1 		$1.84M Buy
+6,851
New +$1.96M 1.1% 33

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mathes Company's AGN Position: Q4 2016 in Review

Mathes Company sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 6,231 shares — an estimated $1.44M sold.

Mathes Company first reported a position in AGN in Q1 2016 and held it in 3 quarters. The position peaked at $1.84M in Q1 2016. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Mathes Company reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Mathes Company sold 6,231 Allergan plc shares in Q4 2016, an estimated $1.44M.
  • Mathes Company first reported a position in Allergan plc in Q1 2016 and held it in 3 quarters.
  • Mathes Company's Allergan plc position peaked at $1.84M in Q1 2016.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Mathes Company's 13F filing for Q4 2016, filed 27 Jan 2017.